Developing a novel tool to assess the ability to self-administer medication in non-demented in-hospital patients: ABLYMED study protocol.

Aged Geriatric assessment Real-life behavior Self administration Treatment adherence and compliance

Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
31 05 2022
Historique:
received: 01 04 2022
accepted: 17 05 2022
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 3 6 2022
Statut: epublish

Résumé

Older people often suffer from multimorbidity resulting in polypharmacy. The correct administration of medication is a crucial factor influencing treatment efficacy. However, tools for evaluating the ability to self-administer different dosage forms of medications are lacking. The objectives of the ABLYMED study are to 1) assess the ability to self-administer different dosage forms of medication in older non-demented in-hospital patients who report autonomous management of medication, 2) identify factors influencing the ability to self-administer medication, and 3) develop a standardized tool to validly assess the ability to self-administer different dosage forms of medications based on the final study results. One hundred in-patients from the department of orthopedics and trauma surgery of the University Hospital Düsseldorf  ≥ 70 years of age and regularly taking ≥ 5 different drugs autonomously will be prospectively recruited into the observational cross-sectional single-center ABLYMED study. Patients undergo an interview addressing demographic and clinical information, medication history (which medications are taken since when, in which dose and dosage form, and subjective proficiency of taking these medications), medication adherence, and factors possibly influencing adherence including personality traits and perceived quality of the medication regimen. Quality of the medication regimen is also rated by clinicians according to validated lists. Further, patients receive a comprehensive geriatric assessment including measures of cognition, mobility, and functional status. The ability to self-administer medication is assessed by having patients perform different tasks related to medication self-administration, which are video recorded and rated by different experts. The patients' self-reported ability will be correlated with the observed performance in the self-administration tasks. Further, factors correlating with the reported and observed ability to self-administer medication will be evaluated using correlation and regression models. Based on the final study results, a novel tool to assess the ability of older patients to self-administer medication will be developed. In addition to guideline-based pharmacotherapy, correct intake of prescribed medication is crucial for optimal therapy of multimorbidity in older people. Tools to validly assess the ability of older patients to self-administer different dosage forms of medications are lacking, but should be included in comprehensive geriatric assessments to secure functional health. Development of an assessment instrument to evaluate the ability to manage various dosage forms, DRKS-ID: DRKS00025788 , (date of registration: 07/09/2021).

Sections du résumé

BACKGROUND
Older people often suffer from multimorbidity resulting in polypharmacy. The correct administration of medication is a crucial factor influencing treatment efficacy. However, tools for evaluating the ability to self-administer different dosage forms of medications are lacking. The objectives of the ABLYMED study are to 1) assess the ability to self-administer different dosage forms of medication in older non-demented in-hospital patients who report autonomous management of medication, 2) identify factors influencing the ability to self-administer medication, and 3) develop a standardized tool to validly assess the ability to self-administer different dosage forms of medications based on the final study results.
METHODS
One hundred in-patients from the department of orthopedics and trauma surgery of the University Hospital Düsseldorf  ≥ 70 years of age and regularly taking ≥ 5 different drugs autonomously will be prospectively recruited into the observational cross-sectional single-center ABLYMED study. Patients undergo an interview addressing demographic and clinical information, medication history (which medications are taken since when, in which dose and dosage form, and subjective proficiency of taking these medications), medication adherence, and factors possibly influencing adherence including personality traits and perceived quality of the medication regimen. Quality of the medication regimen is also rated by clinicians according to validated lists. Further, patients receive a comprehensive geriatric assessment including measures of cognition, mobility, and functional status. The ability to self-administer medication is assessed by having patients perform different tasks related to medication self-administration, which are video recorded and rated by different experts. The patients' self-reported ability will be correlated with the observed performance in the self-administration tasks. Further, factors correlating with the reported and observed ability to self-administer medication will be evaluated using correlation and regression models. Based on the final study results, a novel tool to assess the ability of older patients to self-administer medication will be developed.
DISCUSSION
In addition to guideline-based pharmacotherapy, correct intake of prescribed medication is crucial for optimal therapy of multimorbidity in older people. Tools to validly assess the ability of older patients to self-administer different dosage forms of medications are lacking, but should be included in comprehensive geriatric assessments to secure functional health.
TRIAL REGISTRATION
Development of an assessment instrument to evaluate the ability to manage various dosage forms, DRKS-ID: DRKS00025788 , (date of registration: 07/09/2021).

Identifiants

pubmed: 35641903
doi: 10.1186/s12877-022-03147-8
pii: 10.1186/s12877-022-03147-8
pmc: PMC9158197
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

466

Informations de copyright

© 2022. The Author(s).

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Tuberc Respir Dis (Seoul). 2021 Jan;84(1):46-54
pubmed: 32981292
BMJ. 2020 Jun 18;369:m2023
pubmed: 32554409
Aging (Milano). 1995 Jun;7(3):179-83
pubmed: 8547372
J Eval Clin Pract. 2012 Jun;18(3):515-22
pubmed: 21320239
Med Care. 2002 Sep;40(9):771-81
pubmed: 12218768
J Gerontol A Biol Sci Med Sci. 2001 Jun;56(6):M366-72
pubmed: 11382797
Int J Chron Obstruct Pulmon Dis. 2019 Dec 02;14:2767-2775
pubmed: 31819409
Health Qual Life Outcomes. 2008 Aug 19;6:63
pubmed: 18713451
Br J Clin Pharmacol. 2020 Oct;86(10):1969-1981
pubmed: 31875976
BMC Geriatr. 2018 Oct 11;18(1):239
pubmed: 30305048
PLoS One. 2010 Dec 29;5(12):e15941
pubmed: 21209965
Expert Opin Drug Saf. 2014 Jan;13(1):57-65
pubmed: 24073682
J Eval Clin Pract. 2010 Jun;16(3):574-9
pubmed: 20210821
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Dtsch Arztebl Int. 2010 Aug;107(31-32):543-51
pubmed: 20827352
J Bras Pneumol. 2015 Jul-Aug;41(4):313-22
pubmed: 26398751
Eur J Clin Pharmacol. 1996;49(4):255-9
pubmed: 8857069
PLoS One. 2019 Mar 18;14(3):e0213948
pubmed: 30883587
Br J Clin Pharmacol. 2016 Nov;82(5):1382-1392
pubmed: 27426227
Gerontologist. 2006 Oct;46(5):661-8
pubmed: 17050757
Clin Interv Aging. 2021 Jun 15;16:1095-1104
pubmed: 34163153
Patient Prefer Adherence. 2020 Oct 07;14:1811-1822
pubmed: 33116426
Age Ageing. 2016 Mar;45(2):262-7
pubmed: 26786346
J Am Geriatr Soc. 2012 Apr;60(4):614-5
pubmed: 22376003

Auteurs

Anneke Maiworm (A)

Hospital Pharmacy, University Hospital Düsseldorf, Düsseldorf, Germany.

Robert Langner (R)

Institute of Systems Neuroscience, University Hospital Düsseldorf, Düsseldorf, Germany.
Institute of Neuroscience and Medicine (INM-7: Brain and Behaviour), Research Centre Jülich, Jülich, Germany.

Stefan Wilm (S)

Institute of General Practice, Centre for Health and Society (Chs), University Hospital Düsseldorf, Düsseldorf, Germany.

Dirk M Hermann (DM)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.

Helmut Frohnhofen (H)

Department of Orthopedics and Trauma Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
Faculty of Health, Department of Medicine, Geriatrics, University Witten-Herdecke, Witten, Germany.

Janine Gronewold (J)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany. janine.gronewold@uk-essen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH